← Human Trials & Peer-Reviewed Studies
Effects of HypnoBirthing Training and Oxytocin Massage in Primiparous Pregnants
Plain-language guide to NCT06325839: not phased randomized trial of Oxytocin, 50 participants. Who took part, design and what was measured.
Key Facts
- Registry ID
- NCT06325839
- Phase
- not phased
- Status
- completed
- Start
- 2023-04-01
- Completion (planned or actual)
- 2023-09-10
- Participants
- 50 (actual)
- Design
- randomized, single-blind, supportive_care
- Conditions studied
- Pregnancy Related
- Results posted
- not yet
What This Study Did, in Plain Language
What Was Tested
This registered not phased trial tested Oxytocin.
This study was conducted to determine the effects of hypnobirthing training and oxytocin massage on birth and postpartum period in primiparous pregnant women.
It had two arms (groups): HypnoBirthing training and oxytocin massage group (experimental) and The group without HypnoBirthing training and oxytocin massage (no intervention).
Pregnant women who received HypnoBirthing training and oxytocin massage constituted the experimental group.
Pregnant women who did not receive HypnoBirthing training and oxytocin massage constituted the control group.
The registry classes the interventions as other.
More on the Plan
Hypnobirthing is a birth philosophy and method that prepares women physically and psychologically for giving birth.
It is important to break the fear-tension-pain cycle in HypnoBirthing training.
In this case, the duration of labor is prolonged, birth success, shape, preference, course and satisfaction are negatively affected.
For this purpose, health professionals in the world and in their country are actively involved in pregnancy education programs in which different methods are applied.
Who Took Part
Enrollment: 50 actual participants took part.
It was open to women only aged from 18 years up to 45 years.
Healthy volunteers could join, not only people with the condition.
Examples of who could join: Pregnant women between the ages of 18 and 45,. Able to communicate verbally,. Being in the 36th week of pregnancy,. Having a single fetus,.
The full record lists 5 inclusion and 2 exclusion criteria; among the exclusions: pregnant women at risk; multiparous pregnant women.
How the Study Was Run
Design: randomized, parallel-group and single-blind.
The participants were allocated by chance, so the Oxytocin group and the comparison group should start out alike.
The Oxytocin group and the comparison group ran side by side rather than switching.
Only one side, usually the participants, was kept unaware of whether Oxytocin was given.
Those kept unaware of assignments: participant.
It started in 2023-04-01 with completion listed for 2023-09-10.
It ran at 1 site in Turkey (Türkiye).
Its stated primary purpose is supportive care.
What Was Measured
The main thing measured (primary outcome): Wijma Birth Anticipation/Experience Scale A (W-DEQ-A) (time frame: five weeks).
It also tracked 4 secondary outcomes, for example Wijma Birth Expectancy/Expectation Scale B (W-DEQ-B), Mother-Infant Attachment Scale (MICS) and Birth satisfaction scale short form (BSS-SF).
What This Means in Plain Language
Put simply, this is a not phased, randomized trial of Oxytocin in 50 people.
The trial is marked completed; no results are posted to the registry yet, so nothing here describes outcomes.
More context: the Oxytocin compound page, all human trials.
Our Notes on the Compound
Oxytocin: A peptide hormone with established obstetric medical uses and a less settled role in research on behavior, sexual function and appetite.
Related Pages
Source: ClinicalTrials.gov record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.